| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EVH | Class A Common Stock | Options Exercise | $0 | +400K | +63.85% | $0.00 | 1.03M | Mar 3, 2023 | Direct | F1, F2 |
| transaction | EVH | Class A Common Stock | Sale | -$3.02M | -87.9K | -8.56% | $34.40 | 939K | Mar 6, 2023 | Direct | F2, F3, F4, F5 |
| transaction | EVH | Class A Common Stock | Sale | -$85.9K | -2.46K | -0.26% | $35.01 | 936K | Mar 6, 2023 | Direct | F2, F3, F4, F6 |
| transaction | EVH | Class A Common Stock | Sale | -$4.03M | -116K | -12.42% | $34.62 | 820K | Mar 7, 2023 | Direct | F2, F3, F4, F7 |
| holding | EVH | Class A Common Stock | 66.1K | Mar 3, 2023 | See footnote | F8 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EVH | Leveraged Restricted Stock Unit | Options Exercise | $0 | -400K | -100% | $0.00* | 0 | Mar 3, 2023 | Class A Common Stock | 400K | $0.00 | Direct | F9, F10 |
| Id | Content |
|---|---|
| F1 | Represents the vesting of the leveraged stock units ("LSUs") granted to Mr. Williams on March 2, 2020, based on the cumulative performance of the Issuer's Class A Common Stock. |
| F2 | Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. |
| F3 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2022. |
| F4 | This number represents shares of Class A Common Stock sold to satisfy the tax withholding obligation due upon vesting of LSUs. |
| F5 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.95 to $34.93, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F6 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.975 to $35.060, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F7 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.35 to $34.92, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. |
| F8 | Shares held of record by the Frank Williams Irrevocable Trust. Mr. Williams serves as the Trustee of the Frank Williams Irrevocable Trust. |
| F9 | LSUs vested on March 3, 2023. |
| F10 | These LSUs do not expire. |